8 biotechs that deserve more attention

07/9/2012 | Xconomy

Some biotech firms are developing promising treatments or generating big sales without attracting public attention, Luke Timmerman writes. "Despite all the ways a biotech company can capture public attention, there are lots of companies out there doing good things below the public radar," he writes. He lists advances and achievements by Pharmacyclics, Medivation, Ironwood Pharmaceuticals, Seattle Genetics, Alexion Pharmaceuticals, Cubist Pharmaceuticals, Halozyme Therapeutics and NewLink Genetics.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care